NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/28/2026
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization5.46 mln
Float1.38 mln
Earnings Date11/12/2026
Piotroski F-Score
1
/ 9
Very weak
Relative Strength
1
/ 100
Severely lagging
Debt / Equity
-0.16
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
BioAtla is a San Diego-based company focused on developing antibody-based treatments for solid tumor cancers. Its pipeline includes several advanced drug candidates targeting conditions such as lung cancer, melanoma, sarcoma, and colorectal cancer, among others. Founded in 2007, the company builds its treatments around a proprietary technology that allows its drugs to activate selectively within tumor environments, aiming to improve effectiveness while reducing harm to healthy tissue.
